Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin

The American Journal of Cardiology

Volumn 68, Issue 13, 1991, Pages 1263-1273

  Steering Committee, ^a,b,c   Transdermal Nitroglycerin Cooperative Study, ^a,b,c  

^a PFIZER INC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANGINA PECTORIS; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG TOLERANCE; EXERCISE TEST; FEMALE; HUMAN; MALE; MIDDLE AGE; NITROGLYCERIN; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0025748846     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(91)90229-E     Document Type: Article

References (34)

1. Human pharmacological studies of a new transdermal system containing nitroglycerin
2. Retrospective post-marketing surveillance of Transderm-Nitro five in general practice in the United Kingdom
3. A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual anti-anginal response after repeated administration
4. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris
5. Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectoris
6. Sustained effects of transdermal nitroglycerin in patients with angina pectoris
7. A randomized placebo controlled double-blind crossover trial of transdermal nitroglycerin in stable angina pectoris
8. A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system versus placebo
9. Nitroderm TTS versus oral isosorbide dinitrate: a double-blind trial in patients with angina pectoris
10. Comparison of the prophylactic anti-anginal effect of two doses of Nitroderm TTS in outpatients with stable angina pectoris
11. The anti-anginal effect of transdermally-applied nitroglycerin as a function of the patch size
12. A double-blind multicenter, crossover general practice study of glycerlytrinitrate delivered by a transdermal therapeutic system in stable angina pectoris
13. Transdermal nitroglycerin in angina pectoris
14. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial
15. Transdermal nitroglycerin patches in angina pectoris Dose-titration duration of effects and rapid tolerance
16. Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris
17. Anti-anginal effects of nitroglycerin patches
18. Comparative evaluation of the effect of two doses of Nitroderm TTS on exercise-related parameters in patients with angina pectoris
19. Treatment of coronary artery disease with nitroglycerin patches: response of the anti-ischemic efficacy during continuous use and during use with a patch-free interval
20. Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis
21. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy
22. Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris
23. Nitrate therapy in stable angina pectoris
24. Tolerance in glyceryl trinitrate patches: prevention by intermittent dosing
25. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application
26. Sustained anti-anginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate free interval
27. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina
28. Tolerance development during isosorbide dinitrate treatment Can it be prevented?
29. Anti-ischemic effects of an 80 mg tablet of isosorbide dinitrate in sustained-release form before and after two weeks treatment with 80 mg once daily or twice daily
30. Oral isosorbide dinitrate in the treatment of angina pectoris: dose-response relationship and duration of action during acute therapy
31. Nitrate Tolerance: influence of isosorbide dinitrate on the hemodynamic and anti-anginal effects of nitroglycerin
32. Does tolerance develop to the coronary artery dilatation effects of nitrates?
33. In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries
34. Platelets, vasoconstriction, and nitroglycerin during arterial wall injury, a new antithrombotic role for an old drug